Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Ansell Ltd

Healthcare AU ANN

27.56AUD
-0.04(0.14%)

Last update at 2026-06-04T06:10:00Z

Day Range

27.4127.77
LowHigh

52 Week Range

25.0537.12
LowHigh

Fundamentals

  • Previous Close 27.60
  • Market Cap3836.75M
  • Volume240473
  • P/E Ratio20.82
  • Dividend Yield2.01%
  • EBITDA350.80M
  • Revenue TTM2010.20M
  • Revenue Per Share TTM13.89
  • Gross Profit TTM 847.50M
  • Diluted EPS TTM1.30

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 143.90M 108.70M 189.60M 208.40M 318.10M
Minority interest -2.00000M -1.00000M -1.60000M -1.10000M 13.40M
Net income 101.60M 76.50M 148.30M 158.70M 246.70M
Selling general administrative 641.10M 321.30M 406.20M 429.20M 480.10M
Selling and marketing expenses 641.10M 108.00M 406.20M 429.20M 480.10M
Gross profit 825.00M 624.80M 616.70M 665.80M 810.00M
Reconciled depreciation 74.80M 72.60M 68.00M 65.30M 64.10M
Ebit 185.40M 129.70M 207.20M 226.60M 353.46M
Ebitda 260.20M 202.30M 275.20M 291.90M 401.60M
Depreciation and amortization 74.80M 72.60M 68.00M 65.30M 48.14M
Non operating income net other - - - - -
Operating income 109.10M 56.70M 316.04M 367.31M 439.95M
Other operating expenses 1894.20M 1562.60M 942.13M 1223.75M 989.26M
Interest expense 41.50M 21.00M 17.60M 18.20M 19.40M
Tax provision 40.30M 31.20M 39.70M 48.60M 69.80M
Interest income 6.30M 4.40M 17.70M 24.50M 1.20M
Net interest income -40.00000M -20.60000M -19.40000M -19.70000M -18.20000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 40.30M 31.20M 39.70M 48.60M 69.80M
Total revenue 2003.30M 1619.30M 1655.10M 1952.10M 2026.90M
Total operating expenses 715.90M 495.50M 474.20M 494.50M 544.20M
Cost of revenue 1178.30M 994.50M 1038.40M 1286.30M 1216.90M
Total other income expense net 34.80M -20.60000M -1.50000M -8.50000M 8.10M
Discontinued operations - - - - -
Net income from continuing ops 103.60M 77.50M 149.90M 159.80M 248.30M
Net income applicable to common shares 101.60M 76.50M 148.30M 158.70M 246.70M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 3322.40M 3242.60M 2530.60M 2506.20M 2737.70M
Intangible assets 320.20M 212.50M 214.40M 1049.40M 225.70M
Earning assets - - - - -
Other current assets 38.90M 37.40M 31.10M 38.10M 37.40M
Total liab 1339.70M 1332.40M 915.20M 949.60M 1173.10M
Total stockholder equity 1963.60M 1894.90M 1600.90M 1542.90M 1551.20M
Deferred long term liab - - - - -
Other current liab - 120.40M 367.69M 185.83M 256.72M
Common stock - 1028.20M 750.70M 743.80M 769.00M
Capital stock 1027.00M 1028.20M 750.70M 743.80M 769.00M
Retained earnings 1097.20M 1059.80M 1026.60M 942.00M 866.80M
Other liab - - 123.60M 121.70M 128.50M
Good will 1335.30M 842.30M 845.30M 834.40M 851.40M
Other assets - - 114.10M 95.80M 114.70M
Cash 238.30M 912.30M 159.40M 206.20M 240.20M
Cash and equivalents - - - - -
Total current liabilities 522.00M 423.40M 414.60M 360.30M 549.90M
Current deferred revenue - - -289.89286M -120.02972M -85.01800M
Net debt 460.60M -55.10000M 334.90M 279.60M 275.30M
Short term debt - 77.50M 117.30M 18.20M 20.80M
Short long term debt 60.40M 59.70M 100.00M - -
Short long term debt total - 857.20M 494.30M 485.80M 515.50M
Other stockholder equity - - -2668.43822M -2441.71272M -2181.50288M
Property plant equipment - - 436.80M 356.60M 356.00M
Total current assets 1110.80M 1623.90M 912.00M 984.50M 1166.90M
Long term investments 1.10M 5.60M 6.50M 18.00M 21.90M
Net tangible assets - - 541.20M 493.50M 474.10M
Short term investments - - 11.82M 10.82M 8.77M
Net receivables 306.90M 211.90M 191.20M 201.70M 274.20M
Long term debt 638.50M 706.60M 307.00M 426.30M 451.70M
Inventory 584.70M 457.90M 526.10M 521.30M 611.20M
Accounts payable 250.90M 225.50M 219.50M 276.30M 357.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -193.10000M -176.40000M -142.90000M -84.60000M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 33.80M 42.60M 42.00M 32.60M 32.70M
Deferred long term asset charges - - - - -
Non current assets total 2211.60M 1618.70M 1618.60M 1521.70M 1570.80M
Capital lease obligations 106.70M 90.90M 87.30M 59.50M 63.80M
Long term debt total - - 377.00M 467.60M 494.70M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -703.30000M -63.40000M -75.50000M -5.10000M -1.70000M
Change to liabilities - - -78.90000M -94.70000M 124.20M
Total cashflows from investing activities -703.30000M -63.40000M -75.50000M -71.20000M -84.70000M
Net borrowings -82.00000M 360.70M -59.50000M -17.10000M -112.10000M
Total cash from financing activities -216.00000M 540.80M -149.20000M -176.70000M -267.50000M
Change to operating activities - - 0.70M -48.90000M 16.10M
Net income 101.60M 76.50M 222.66M 229.86M 329.00M
Change in cash -674.00000M 752.90M -46.80000M -34.00000M -168.70000M
Begin period cash flow 912.30M 159.40M 206.20M 240.20M 408.90M
End period cash flow 238.30M 912.30M 159.40M 206.20M 240.20M
Total cash from operating activities 239.30M 272.30M 271.00M 321.54M 230.45M
Issuance of capital stock - 305.20M 0.30M 103.20M -
Depreciation - 72.60M 96.99M 87.19M 76.55M
Other cashflows from investing activities 1.30M -0.60000M -8.30000M -3.70000M -2.00000M
Dividends paid -63.70000M -53.20000M 62.90M 86.80M 77.30M
Change to inventory - 61.40M 13.21M 98.35M -347.40280M
Change to account receivables - -23.00000M 22.22M 85.60M -107.88824M
Sale purchase of stock -4.40000M -30.00000M -8.00000M -48.50000M -58.00000M
Other cashflows from financing activities -65.90000M -41.90000M -19.20000M -45.80000M -20.80000M
Change to netincome - - 15.10M 32.90M 46.70M
Capital expenditures 69.30M 62.80M 67.30M 72.60M 82.70M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 6.60M 37.60M 35.43M 183.95M -455.29104M
Stock based compensation - 6.20M -8.25770M -3.76584M 40.14M
Other non cash items 239.30M 79.40M -48.64536M 4.49M -175.10168M
Free cash flow 170.00M 208.60M 203.70M 248.94M 147.75M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ANN
Ansell Ltd		 -0.04 0.14% 27.56 20.82 16.61 1.91 1.40 1.66 11.05
RMD
Resmed Inc		 0.66 2.55% 26.50 19.97 17.76 7.59 4.70 5.30 13.47
FPH
Fisher & Paykel Healthcare Corporation Ltd		 0.13 0.43% 30.40 51.75 42.37 7.90 11.31 15.26 29.64
NAN
Nanosonics Ltd		 -0.06 1.90% 3.10 45.57 46.30 4.60 4.41 3.93 25.73
SDI
SDI Ltd		 -0.01 0.74% 1.35 13.45 5.06 1.43 1.55 1.54 8.42

Reports Covered

Stock Research & News

View All

Profile

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Ansell Ltd

678 Victoria Street, Richmond, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Neil I. Salmon ACMA, BA MD, CEO & Director 1969
Mr. Zubair Javeed Chief Financial Officer NA
Mr. Darryl Nazareth Pres of Healthcare GBU NA
Mr. Rikard Fröberg MA, MS Pres of the Industrial Global Bus. Unit (IGBU) NA
Mr. John Marsden Sr. VP of Global Operations & Global Supply Chain NA
Ms. Deanna Johnston Sr. VP & Global Chief Information Officer NA
Michael Evans Director of Corp. Devel. & Investor Relation NA
Mr. Michael Gilleece Sr. VP & Corp. Gen. Counsel NA
Ms. Amanda Manzoni Chief HR Officer NA
Mr. Francois Le Jeune BS, MBA, MS Chief Commercial Officer of EMEA, APAC & Guardian Admin. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.